Aptamer Sciences
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- $13M
Investors
- 9
About Aptamer Sciences
Founded in 2011 and based in South Korea, Aptamer Sciences Inc. is a biotechnology company focused on commercializing technologies for the analysis of proteins. In 2016, Aptamer Sciences Inc. The company applies aptamer-based technology to develop new drugs for various diseases. The company's product pipeline includes ApDC for solid rock and brain tumor, Chimeric Aptamer for Parkinson's disease and immune cancer, and aptamer for diabetes and covid-19. The company also provides services including aptamer synthesis services and aptamer excavation services.
Who invested in Aptamer Sciences
9 investors across 2 rounds
See all investors in Aptamer Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aptamer Sciences
Who invested in Aptamer Sciences?
Aptamer Sciences has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aptamer Sciences raised?
Aptamer Sciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aptamer Sciences last raise money?
Aptamer Sciences's most recent round on record is a Series B, in Jul 2018.
What does Aptamer Sciences do?
Founded in 2011 and based in South Korea, Aptamer Sciences Inc.
Where is Aptamer Sciences headquartered?
Aptamer Sciences is headquartered in Pohang, South Korea.
Which VCs invest in companies like Aptamer Sciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Aptamer Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aptamer Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.